MedPath

GRUNENTHAL PHARMA SAU

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product

Phase 1
Completed
Conditions
Bioequivalence
Interventions
Drug: Desogestrel 0.075 MG
First Posted Date
2020-06-09
Last Posted Date
2020-06-09
Lead Sponsor
Laboratorios Andromaco S.A.
Target Recruit Count
30
Registration Number
NCT04422028
Locations
🇨🇱

Innolab, Santiago, Chile

Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

First Posted Date
2020-01-18
Last Posted Date
2021-02-10
Lead Sponsor
Laboratorios Andromaco S.A.
Target Recruit Count
30
Registration Number
NCT04230070
Locations
🇨🇱

Innolab, Santiago, Chile

Bioavailability of Dienogest 2.0 mg With Regards to Reference Product

Phase 1
Completed
Conditions
Bioequivalence
Interventions
Drug: Dienogest 2.0 mg Test Drug
Drug: Dienogest 2.0 mg Reference Product
First Posted Date
2020-01-18
Last Posted Date
2020-01-18
Lead Sponsor
Laboratorios Andromaco S.A.
Target Recruit Count
30
Registration Number
NCT04230083
Locations
🇨🇱

Innolab, Santiago, Chile

Bioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product

First Posted Date
2019-12-11
Last Posted Date
2021-02-10
Lead Sponsor
Laboratorios Andromaco S.A.
Target Recruit Count
10
Registration Number
NCT04194905
Locations
🇨🇱

Innolab, Santiago, Chile

Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product

First Posted Date
2019-12-10
Last Posted Date
2019-12-10
Lead Sponsor
Laboratorios Andromaco S.A.
Target Recruit Count
10
Registration Number
NCT04193852
Locations
🇨🇱

Innolab, Santiago, Chile

Pharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)

First Posted Date
2019-05-30
Last Posted Date
2019-05-30
Lead Sponsor
Laboratorios Andromaco S.A.
Target Recruit Count
46
Registration Number
NCT03967964
Locations
🇨🇱

Instituto de Investigación Materno Infantil (IDIMI) - Maternidad Hospital San Borja (HCSBA), Santiago, Chile

Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve

Phase 1
Completed
Conditions
Healthy Women
Infertility, Female
Interventions
Drug: Another Androgenic Agent (VRaA)
Drug: Fixed combination of 2 androgenic agents (VR2A)
Drug: DHEA
First Posted Date
2014-10-20
Last Posted Date
2019-05-29
Lead Sponsor
Laboratorios Andromaco S.A.
Target Recruit Count
94
Registration Number
NCT02268032
Locations
🇨🇱

Mother and Health Research Institute (IDIMI), Faculty of Medicine, University of Chile, Santiago, International, Chile

Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea

Phase 2
Completed
Conditions
Dysmenorrhea
Interventions
Drug: Placebo Oral
Drug: Meloxicam
Drug: Diclofenac Potassium
Drug: Placebo Vaginal
First Posted Date
2014-10-02
Last Posted Date
2019-05-03
Lead Sponsor
Laboratorios Andromaco S.A.
Target Recruit Count
68
Registration Number
NCT02255045
Locations
🇨🇱

Instituto Chileno de Medicina Reproductiva (ICMER), Santiago, Chile

Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile Women

Phase 1
Completed
Conditions
Contraception
Bleeding Pattern
Interventions
Drug: Meloxicam 2.4 g
Drug: Meloxicam 3.0 g
First Posted Date
2013-04-25
Last Posted Date
2019-04-30
Lead Sponsor
Laboratorios Andromaco S.A.
Target Recruit Count
13
Registration Number
NCT01839643
Locations
🇨🇱

Instituto Chileno de Medicina Reproductiva (ICMER), Santiago, Chile

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy